HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients
about
HLA-DR15 haplotype and multiple sclerosis: a HuGE reviewOptic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up studyLoss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 miceGenetic contribution to multiple sclerosis risk among Ashkenazi Jews.DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).The immunogenetics of multiple sclerosis: A comprehensive review.HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gammaBalancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic miceVitamin D and multiple sclerosis: a critical review and recommendations on treatment.HLA-DRB and HLA-DQA/HLA-DQB allele and haplotype frequencies in Iranian patients with aggressive periodontitis.HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population.Population screening for association of mitochondrial haplogroups BM, J, K and M with multiple sclerosis: interrelation between haplogroup J and MS in Persian patients.HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
P2860
Q28290714-8671ED08-225F-4126-9FAF-3635B9BFA2E4Q28299499-18C26682-4DEB-471E-984B-4957E3313F9CQ34254430-BAE57F57-2AE6-42E9-ABB1-91E919F06CECQ35714739-8A3C97AA-CA2A-4580-82E3-56F4D435289EQ35935131-6CDA1B26-4ACD-46E5-B884-9496A7B3F8D8Q36394834-219B7158-8ECA-418C-8502-A2354FB04FDEQ36958285-55FC9D84-BB73-4F11-BFAE-9344B07AFC90Q37077497-5B2AB507-A811-4C34-B7A6-96DAFC5479C7Q37151283-DDAFD6C6-827F-43EB-A339-C5D473945904Q37590908-FC45B093-3D12-4D40-9DD3-F811C3D044FFQ37883681-1D25E7D7-BDD5-455C-9C86-FFB6A2768E8EQ38024285-BD11047B-E47D-4F7B-AD01-E72ECB639FCCQ42278883-8FF83336-5658-4B86-831F-55D28176720AQ44018063-9AEBC129-C2DC-4E15-BD45-5EF9F9710FFAQ51312107-72CEC5F4-B137-4225-8E0F-98EBF202EB5AQ53165441-2A87AEEB-D8BF-43B9-AAA6-CA937FF6AB38
P2860
HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@ast
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@en
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@nl
type
label
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@ast
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@en
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@nl
prefLabel
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@ast
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@en
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@nl
P2093
P1476
HLA class II (DRB1, DQA1 and D ...... ltiple sclerosis (MS) patients
@en
P2093
A Amirzargar
A Yousefipour
J Mytilineos
P304
P356
10.1046/J.1365-2370.1998.00101.X
P407
P577
1998-08-01T00:00:00Z